The food glycome: A source of protection against pathogen colonization in the gastrointestinal tract

International Journal of Food Microbiology

Volumn 142, Issue 1-2, 2010, Pages 1-13

  Lane, Jonathan A ^a,b   Mehra, Raj K ^a   Carrington, Stephen D ^b   Hickey, Rita M ^a  

^a TEAGASC FOOD RESEARCH CENTRE   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Anti adhesion; Carbohydrates; Nutraceutical; Pathogens

Indexed keywords

3' SIALYLLACTOSE; BISMUTH SALICYLATE; CARBOHYDRATE; GLYCAN; NUTRACEUTICAL; OLIGOSACCHARIDE; OMEPRAZOLE; PROBIOTIC AGENT; SIALYLOLIGOSACCHARIDE; UNCLASSIFIED DRUG;

BACTERIAL COLONIZATION; BACTERIUM ADHERENCE; BIFIDOBACTERIUM; BLOOD GROUP ABO SYSTEM; BLOOD GROUP LEWIS SYSTEM; BREAST MILK; CAMPYLOBACTER JEJUNI; CARBOHYDRATE ANALYSIS; CARBOHYDRATE DIET; CLOSTRIDIUM DIFFICILE; DISEASE COURSE; EGG YOLK; GASTROINTESTINAL INFECTION; GASTROINTESTINAL TRACT; HELICOBACTER PYLORI; HONEY; HOST CELL; HUMAN; INFECTION PREVENTION; INTESTINE FLORA; LACTOBACILLUS; MILK; NONHUMAN; PATHOGENICITY; REVIEW;

BACTERIA; BACTERIAL ADHESION; CAMPYLOBACTER JEJUNI; CLOSTRIDIUM DIFFICILE; DIETARY CARBOHYDRATES; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; HELICOBACTER PYLORI; HUMANS;

CAMPYLOBACTER JEJUNI; CLOSTRIDIUM DIFFICILE; HELICOBACTER PYLORI;

EID: 77955652772     PISSN: 01681605     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijfoodmicro.2010.05.027     Document Type: Review

References (162)

1. Abuoun M., Manning G., Cawthraw S.A., Ridley A., Ahmed I.H., Wassenaar T.M., Newell D.G. Cytolethal distending toxin (CDT)-negative Campylobacter jejuni strains and anti-CDT neutralizing antibodies are induced during human infection but not during colonization in chickens. Infection and Immunity 2005, 73:3053-3062.
2. Altekruse S.F., Stern N.J., Fields P.I., Swerdlow D.L. Campylobacter jejuni-an emerging foodborne pathogen. Emerging Infectious Diseases 1999, 5:28-35.
3. Angstrom J., Teneberg S., Milh M.A., Larsson T., Leonardsson I., Olsson B.M., Halvarsson M.O., Danielsson D., Naslund I., Ljungh A., Wadstrom T., Karlsson K.A. The lactosylceramide binding specificity of Helicobacter pylori. Glycobiology 1998, 8:297-309.
4. Argent R.H., Hale J.L., El-Omar E.M., Atherton J.C. Differences in Helicobacter pylori CagA tyrosine phosphorylation motif patterns between western and East Asian strains, and influences on interleukin-8 secretion. Journal of Medical Microbiology 2008, 57:1062-1067.
5. Ashgar S.S., Oldfield N.J., Wooldridge K.G., Jones M.A., Irving G.J., Turner D.P., Ala'Aldeen D.A. CapA, an autotransporter protein of Campylobacter jejuni, mediates association with human epithelial cells and colonization of the chicken gut. Journal of Bacteriology 2007, 189:1856-1865.
6. Aspholm-Hurtig M., Dailide G., Lahmann M., Kalia A., Ilver D., Roche N., Vikstrom S., Sjostrom R., Linden S., Backstrom A., Lundberg C., Arnqvist A., Mahdavi J., Nilsson U.J., Velapatino B., Gilman R.H., Gerhard M., Alarcon T., Lopez-Brea M., Nakazawa T., Fox J.G., Correa P., Dominguez-Bello M.G., Perez-Perez G.I., Blaser M.J., Normark S., Carlstedt I., Oscarson S., Teneberg S., Berg D.E., Boren T. Functional adaptation of BabA, the H. pylori ABO blood group antigen binding adhesin. Science 2004, 305:519-522.
7. Balmer S.E., Wharton B.A. Diet and faecal flora in the newborn: breast milk and infant formula. Archives of Disease in Childhood 1989, 64:1672-1677.
8. Bavington C., Page C. Stopping bacterial adhesion: a novel approach to treating infections. Respiration 2005, 72:335-344.
9. Benno Y., Sawada K., Mitsuoka T. The intestinal microflora of infants: composition of fecal flora in breast-fed and bottle-fed infants. Microbiology and Immunology 1984, 28:975-986.
10. Bio-N'garagba M.C., Louisot P. Regulation of the intestinal glycoprotein glycosylation during postnatal development: role of hormonal and nutritional factors. International Journal of Biochemistry and Molecular Biology 2003, 85:331-352.
11. Bishop J.R., Gagneux P. Evolution of carbohydrate antigens - microbial forces shaping host glycomes?. Glycobiology 2007, 17:23r-34r.
12. Boat T.F., Davis J., Stern R.C., Cheng P.W. Effect of blood group determinants on binding of human salivary mucous glycoproteins to influenza virus. Biochimica et Biophysica Acta 1978, 540:127-133.
13. Bode L. Recent advances on structure, metabolism, and function of human milk oligosaccharides. Journal of Nutrition 2006, 136:2127-2130.
14. Boehm G., Stahl B. Oligosaccharides 2003, Woodhead Publishing Limited, Cambridge, England.
15. Borriello S.P. Pathogenesis of Clostridium difficile infection. Journal of Antimicrobial Chemotherapy 1998, 41:13-19. Suppl C.
16. Bry L., Falk P.G., Midtvedt T., Gordon J.I. A model of host-microbial interactions in an open mammalian ecosystem. Science 1996, 273:1380-1383.
17. Busch C., Aktories K. Microbial toxins and the glycosylation of Rho family GTPases. Current Opinion in Structural Biology 2000, 10:528-535.
18. Calander N., Karlsson K.A., Nyholm P.G., Pascher I. On the dissection of binding epitopes on carbohydrate receptors for microbes using molecular modelling. Biochimie 1988, 70:1673-1682.
19. Candela M., Perna F., Carnevali P., Vitali B., Ciati R., Gionchetti P., Rizzello F., Campieri M., Brigidi P. Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production. International Journal of Food Microbiology 2008, 125:286-292.
20. Carrington S., Clyne M., Reid C., FitzPatrick E., Moran A. Microbial interaction with mucus and mucins. Microbial Glycobiology: Structures, Relevance and Applications 2009, Elsevier, London. A. Moran, P. Brennan, O. Holst, M. von Itzstein (Eds.).
21. Carroll I.M., Threadgill D.W., Threadgill D.S. The gastrointestinal microbiome: a malleable, third genome of mammals. Mammalian Genome 2009, 20:395-403.
22. Cervantes L.E., Newburg D.S., Ruizpalacios G.M. α-1-2 Fucosylated chains (H-2 and Lewis-B) are the main human-milk receptor analogs for Campylobacter. Pediatric Research 1995, 37:A171-A171.
23. Comolli J.C., Waite L.L., Mostov K.E., Engel J.N. Pili binding to asialo-GM1 on epithelial cells can mediate cytotoxicity or bacterial internalization by Pseudomonas aeruginosa. Infection and Immunity 1999, 67:3207-3214.
24. Coppa G.V., Bruni S., Zampini L., Galeazzi T., Gabrielli O. Oligosaccharides of human milk inhibit the adhesion of Listeria monocytogenes to Caco-2 cells. Italian Journal of Pediatrics 2003, 29:61-68.
25. Coppa G.V., Bruni S., Morelli L., Soldi S., Gabrielli O. The first prebiotics in humans: human milk oligosaccharides. Journal of Clinical Gastroenterology 2004, 38:S80-S83.
26. Coppa G.V., Zampini L., Galeazzi T., Facinelli B., Ferrante L., Capretti R., Orazio G. Human milk oligosaccharides inhibit the adhesion to Caco-2 cells of diarrheal pathogens: Escherichia coli, Vibrio cholerae, and Salmonella fyris. Pediatric Research 2006, 59:377-382.
27. Cordwell S.J., Len A.C., Touma R.G., Scott N.E., Falconer L., Jones D., Connolly A., Crossett B., Djordjevic S.P. Identification of membrane-associated proteins from Campylobacter jejuni strains using complementary proteomics technologies. Proteomics 2008, 8:122-139.
28. Costa A.C., Figueiredo C., Touati E. Pathogenesis of Helicobacter pylori infection. Helicobacter 2009, 14:15-20.
29. Cover T.L., Blanke S.R. Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nature Reviews in Microbiology 2005, 4:320-332.
30. Cravioto A., Tello A., Villafan H., Ruiz J., del Vedovo S., Neeser J.R. Inhibition of localized adhesion of enteropathogenic Escherichia coli to HEp-2 cells by immunoglobulin and oligosaccharide fractions of human colostrum and breast milk. Journal of Infectious Diseases 1991, 163:1247-1255.
31. Daddaoua A., Puerta V., Requena P., Martinez-Ferez A., Guadix E., de Medina F.S., Zarzuelo A., Suarez M.D., Boza J.J., Martinez-Augustin O. Goat milk oligosaccharides are anti-inflammatory in rats with hapten-induced colitis. Journal of Nutrition 2006, 136:672-676.
32. Dai D.W., Nanthkumar N.N., Newburg D.S., Walker W.A. Role of oligosaccharides and glycoconjugates in intestinal host defense. Journal of Pediatric Gastroenterology and Nutrition 2000, 30:S23-S33.
33. Dallas S.D., Rolfe R.D. Binding of Clostridium difficile toxin A to human milk secretory component. Journal of Medical Microbiology 1998, 47:879-888.
34. Dasti J.I., Tareen A.M., Lugert R., Zautner A.E., Gross U. Campylobacter jejuni: a brief overview on pathogenicity-associated factors and disease-mediating mechanisms. International Journal of Medical Microbiology 2009, 300(4):205-211.
35. Dawson L.F., Valiente E., Wren B.W. Clostridium difficile-a continually evolving and problematic pathogen. Infection, Genetics and Evolution 2009, 9:1410-1417.
36. Day C.J., Tiralongo J., Hartnell R.D., Logue C.A., Wilson J.C., von Itzstein M., Korolik V. Differential carbohydrate recognition by Campylobacter jejuni strain 11168: influences of temperature and growth conditions. PLoS One 2009, 4:e4927.
37. Deneve C., Delomenie C., Barc M.C., Collignon A., Janoir C. Antibiotics involved in Clostridium difficile-associated disease increase colonization factor gene expression. Journal of Medical Microbiology 2008, 57:732-738.
38. Dharmani P., Srivastava V., Kissoon-Singh V., Chadee K. Role of intestinal mucins in innate host defense mechanisms against pathogens. Journal of Innate Immunity 2009, 1:123-135.
39. Dubreuil J.D., Giudice G.D., Rappuoli R. Helicobacter pylori interactions with host serum and extracellular matrix proteins: potential role in the infectious process. Microbiology and Molecular Biology Reviews 2002, 66:617-629.
40. Duerkop B.A., Vaishnava S., Hooper L.V. Immune responses to the microbiota at the intestinal mucosal surface. Immunity 2009, 31:368-376.
41. Egge H. The diversity of oligosaccharides in human milk. New Perspectives in Infant Nutrition 1993, 12-26. Thieme, Stuttgart, New York. B. Renner, G. Sawatzki (Eds.).
42. Evans D.J., Evans D.G. Helicobacter pylori adhesins: review and perspectives. Helicobacter 2000, 5:183-195.
43. Favier C.F., Vaughan E.E., De Vos W.M., Akkermans A.D. Molecular monitoring of succession of bacterial communities in human neonates. Applied and Environmental Microbiology 2002, 68:219-226.
44. Fields J.A., Thompson S.A. Campylobacter jejuni CsrA mediates oxidative stress responses, biofilm formation, and host cell invasion. Journal of Bacteriology 2008, 190:3411-3416.
45. Finke B., Stahl B., Pfenninger A., Karas M., Daniel H., Sawatzki G. Analysis of high-molecular-weight oligosaccharides from human milk by liquid chromatography and MALDI-MS. Analytical Chemistry 1999, 71:3755-3762.
46. Fooks L.J., Gibson G.R. In vitro investigations of the effect of probiotics and prebiotics on selected human intestinal pathogens. FEMS Microbiology Ecology 2002, 39:67-75.
47. Garrow D., Delegge M.H. Risk factors for gastrointestinal ulcer disease in the US population. Digestive Diseases and Sciences 2009, 55:66-72.
48. Gerding D.N. Clostridium difficile 30years on: what has, or has not, changed and why?. International Journal of Antimicrobial Agents 2009, 33(Suppl 1):S2-S8.
49. Glass R.I., Holmgren J., Haley C.E., Khan M.R., Svennerholm A.M., Stoll B.J., Hossain K.M.B., Black R.E., Yunus M., Barua D. Predisposition for cholera of individuals with O-blood group - possible evolutionary significance. American Journal of Epidemiology 1985, 121:791-796.
50. Gordon J.I., Stappenbeck T.S., Hooper L.V. Response from Jeffrey I. Gordon et al.: Commensal bacteria make a difference. Trends in Microbiology 2003, 11:150-151.
51. Gornik O., Dumic J., Flogel M., Lauc G. Glycoscience - a new frontier in rational drug design. Acta Pharmaceutica 2006, 56:19-30.
52. Gorschluter M., Glasmacher A., Hahn C., Schakowski F., Ziske C., Molitor E., Marklein G., Sauerbruch T., Schmidt-Wolf I.G. Clostridium difficile infection in patients with neutropenia. Clinical Infectious Diseases 2001, 33:786-791.
53. Greco A., Ho J.G., Lin S.J., Palcic M.M., Rupnik M., Ng K.K. Carbohydrate recognition by Clostridium difficile toxin A. Nature Structural & Molecular Biology 2006, 13:460-461.
54. Groschwitz K.R., Hogan S.P. Intestinal barrier function: molecular regulation and disease pathogenesis. Journal of Allergy and Clinical Immunology 2009, 124:3-20. quiz 21-22.
55. Gueimonde M., Jalonen L., He F., Hiramatsu M., Salminen S. Adhesion and competitive inhibition and displacement of human enteropathogens by selected lactobacilli. Food Research International 2006, 39:467-471.
56. Guerry P., Szymanski C.M. Campylobacter sugars sticking out. Trends in Microbiology 2008, 16:428-435.
57. Gustafsson A., Hultberg A., Sjostrom R., Kacskovics I., Breimer M.E., Boren T., Hammarstrom L., Holgersson J. Carbohydrate-dependent inhibition of Helicobacter pylori colonization using porcine milk. Glycobiology 2006, 16:1-10.
58. Hakkarainen J., Toivanen M., Leinonen A., Frangsmyr L., Stromberg N., Lapinjoki S., Nassif X., Tikkanen-Kaukanen C. Human and bovine milk oligosaccharides inhibit Neisseria meningitidis pili attachment in vitro. Journal of Nutrition 2005, 135:2445-2448.
59. Harmsen H.J., Wildeboer-Veloo A.C., Raangs G.C., Wagendorp A.A., Klijn N., Bindels J.G., Welling G.W. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. Journal of Pediatric Gastroenterology and Nutrition 2000, 30:61-67.
60. Hata Y., Murakami M., Okabe S. Glycoconjugates with NeuAc-NeuAc-GaL-Glc are more effective at preventing adhesion of Helicobacter pylori to gastric epithelial cells than glycoconjugates with NeuAc-Gal-Glc. Journal of Physiology and Pharmacology 2004, 55:607-625.
61. Hickey R.M. Harnessing milk oligosaccharides for nutraceutical applications. Dairy-derived Ingredients Food and Nutraceutical Uses 2009, 308-343. University of Guelph, Canada. M. Corredig (Ed.).
62. Hirmo S., Kelm S., Iwersen M., Hotta K., Goso Y., Ishihara K., Suguri T., Morita M., Wadstrom T., Schauer R. Inhibition of Helicobacter pylori sialic acid-specific haemagglutination by human gastrointestinal mucins and milk glycoproteins. FEMS Immunology and Medical Microbiology 1998, 20:275-281.
63. Hopkins M.J., Macfarlane G.T. Nondigestible oligosaccharides enhance bacterial colonization resistance against Clostridium difficile in vitro. Applied and Environmental Microbiology 2003, 69:1920-1927.
64. Hu L., Bray M.D., Osorio M., Kopecko D.J. Campylobacter jejuni induces maturation and cytokine production in human dendritic cells. Infection and Immunity 2006, 74:2697-2705.
65. Hutson A.M., Atmar R.L., Graham D.Y., Estes M.K. Norwalk virus infection and disease is associated with ABO histo-blood group type. Journal of Infectious Diseases 2002, 185:1335-1337.
66. Idota T., Kawakami H. Inhibitory effects of milk ganglioside on the adhesion of Escherichia coli to human intestinal carcinoma cells. Bioscience, Biotechnology, and Biochemistry 1995, 59:69-72.
67. Ikehara Y., Nishihara S., Yasutomi H., Kitamura T., Matsuo K., Shimizu N., Inada K.I., Kodera Y., Yamamura Y., Narimatsu H., Hamajima N., Tatematsu M. Polymorphisms of two fucosyltransferase genes (Lewis and Secretor genes) involving type I Lewis antigens are associated with the presence of anti-Helicobacter pylori IgG antibody. Cancer Epidemiology Biomarkers and Prevention 2001, 10:971-977.
68. Ilver D., Arnqvist A., Ogren J., Frick I.M., Kersulyte D., Incecik E.T., Berg D.E., Covacci A., Engstrand L., Boren T. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 1998, 279:373-377.
69. Janssen R., Krogfelt K.A., Cawthraw S.A., van Pelt W., Wagenaar J.A., Owen R.J. Host-pathogen interactions in Campylobacter infections: the host perspective. Clinical Microbiology Reviews 2008, 21:505-518.
70. Jin S., Joe A., Lynett J., Hani E.K., Sherman P., Chan V.L. JlpA, a novel surface-exposed lipoprotein specific to Campylobacter jejuni, mediates adherence to host epithelial cells. Molecular Microbiology 2001, 39:1225-1236.
71. Jin S., Song Y.C., Emili A., Sherman P.M., Chan V.L. JlpA of Campylobacter jejuni interacts with surface-exposed heat shock protein 90alpha and triggers signalling pathways leading to the activation of NF-kappaB and p38 MAP kinase in epithelial cells. Cellular Microbiology 2003, 5:165-174.
72. Johansson M.E., Phillipson M., Petersson J., Velcich A., Holm L., Hansson G.C. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proceedings of the National Academy of Science of the United States of America 2008, 105:15,064-15,069.
73. Kelly D., Conway S., Aminov R. Commensal gut bacteria: mechanisms of immune modulation. Trends in Immunology 2005, 26:326-333.
74. Koketsu M., Nitoda T., Juneja L.R., Mujo K., Kashimura N., Yamamoto T. Sialyloligosaccharides from egg yolk as an inhibitor of rotaviral infection. Journal of Agricultural Food Chemistry 1995, 43:858-861.
75. Konkel M.E., Christensen J.E., Keech A.M., Monteville M.R., Klena J.D., Garvis S.G. Identification of a fibronectin-binding domain within the Campylobacter jejuni CadF protein. Molecular Microbiology 2005, 57:1022-1035.
76. Kunz C., Rudloff S. Health promoting aspects of milk oligosaccharides. International Dairy Journal 2006, 16:1341-1346.
77. Kunz C., Rudloff S., Baier W., Klein N., Strobel S. Oligosaccharides in human milk: structural, functional, and metabolic aspects. Annual Review of Nutrition 2000, 20:699-722.
78. Kusters J.G., van Vliet A.H., Kuipers E.J. Pathogenesis of Helicobacter pylori infection. Clinical Microbiology Reviews 2006, 19:449-490.
79. Lara-Villoslada F., Debras E., Nieto A., Concha A., Galvez J., Lopez-Huertas E., Boza J., Obled C., Xaus J. Oligosaccharides isolated from goat milk reduce intestinal inflammation in a rat model of dextran sodium sulfate-induced colitis. Clinical Nutrition 2006, 25:477-488.
80. Lee J.H., Park E.K., Uhm C.S., Chung M.S., Kim K.H. Inhibition of Helicobacter pylori adhesion to human gastric adenocarcinoma epithelial cells by acidic polysaccharides from Artemisia capillaris and Panax ginseng. Planta Medica 2004, 70:615-619.
81. Lengsfeld C., Deters A., Faller G., Hensel A. High molecular weight polysaccharides from black currant seeds inhibit adhesion of Helicobacter pylori to human gastric mucosa. Planta Medica 2004, 70:620-626.
82. Lenoir D., Ruggiero-Lopez D., Louisot P., Biol M.C. Developmental changes in intestinal glycosylation: nutrition-dependent multi-factor regulation of the fucosylation pathway at weaning time. Biochimica et Biophysica Acta 1995, 1234:29-36.
83. Lenoir D., Greco S., Louisot P., Biol M.C. Implication of insulin and nutritional factors in the regulation of intestinal galactosyltransferase activity during postnatal development. Metabolism-Clinical and Experimental 2000, 49:526-531.
84. Lerrer B., Zinger-Yosovich K.D., Avrahami B., Gilboa-Garber N. Honey and royal jelly, like human milk, abrogate lectin-dependent infection-preceding Pseudomonas aeruginosa adhesion. ISME Journal 2007, 1:149-155.
85. Liéven-Le Moal V., Servin A.L. The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota. Clinical Microbiology Reviews 2006, 19:315-337.
86. Lindberg A.A., Brown J.E., Stromberg N., Westling-Ryd M., Schultz J.E., Karlsson K.A. Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1. Journal of Biological Chemistry 1987, 262:1779-1785.
87. Linden S.K., Sutton P., Karlsson N.G., Korolik V., McGuckin M.A. Mucins in the mucosal barrier to infection. Mucosal Immunology 2008, 1:183-197.
88. Linden S.K., Wickstrom C., Lindell G., Gilshenan K., Carlstedt I. Four modes of adhesion are used during Helicobacter pylori binding to human mucins in the oral and gastric niches. Helicobacter 2008, 13:81-93.
89. Linden S.K., Sheng Y.H., Every A.L., Miles K.M., Skoog E.C., Florin T.H., Sutton P., McGuckin M.A. MUC1 limits Helicobacter pylori infection both by steric hindrance and by acting as a releasable decoy. PLoS Pathogens 2009, 5:e1000617.
90. Lindsay D., von Holy A. Bacterial biofilms within the clinical setting: what healthcare professionals should know. Journal of Hospital Infection 2006, 64:313-325.
91. Louwen R., Heikema A., van Belkum A., Ott A., Gilbert M., Ang W., Endtz H.P., Bergman M.P., Nieuwenhuis E.E. The sialylated lipooligosaccharide outer core in Campylobacter jejuni is an important determinant for epithelial cell invasion. Infection and Immunity 2008, 76:4431-4438.
92. Mack D.R., Michail S., Wei S., McDougall L., Hollingsworth M.A. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. AJP - Gastrointestinal and Liver Physiology 1999, 276:G941-G950.
93. Macpherson A.J., Gatto D., Sainsbury E., Harriman G.R., Hengartner H., Zinkernagel R.M. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science 2000, 288:2222-2226.
94. Matrosovich M.N., Gambaryan A.S., Tuzikov A.B., Byramova N.E., Mochalova L.V., Golbraikh A.A., Shenderovich M.D., Finne J., Bovin N.V. Probing of the receptor-binding sites of the H1 and H3 influenza A and influenza B virus hemagglutinins by synthetic and natural sialosides. Virology 1993, 196:111-121.
95. Matsumoto M., Hara K., Kimata H., Benno Y., Shimamoto C. Exfoliation of Helicobacter pylori from gastric mucin by glycopolypeptides from buttermilk. Journal of Dairy Science 2005, 88:49-54.
96. McVeagh P., Miller J.B. Human milk oligosaccharides: only the breast. Journal of Paediatrics and Child Health 1997, 33:281-286.
97. Mehra R., Kelly P. Milk oligosaccharides: structural and technological aspects. International Dairy Journal 2006, 16:1334-1340.
98. Millar M.R., Linton C.J., Cade A., Glancy D., Hall M., Jalal H. Application of 16S rRNA gene PCR to study bowel flora of preterm infants with and without necrotizing enterocolitis. Journal of Clinical Microbiology 1996, 34:2506-2510.
99. Moncada D.M., Kammanadiminti S.J., Chadee K. Mucin and toll-like receptors in host defense against intestinal parasites. Trends in Parasitology 2003, 19:305-311.
100. Moran A.P. Relevance of fucosylation and Lewis antigen expression in the bacterial gastroduodenal pathogen Helicobacter pylori. Carbohydrate Research 2008, 343:1952-1965.
101. Moran A., Holst O., Brennan P., von Itzstein M. Microbial glycobiology. Microbial Glycobiology: Structures, Relevance and Applications 2009, Elsevier, London. A. Moran, O. Holst, P. Brennan, M. von Itzstein (Eds.).
102. Moreau M.C., Thomasson M., Ducluzeau R., Raibaud P. Kinetics of establishment of digestive microflora in the human newborn infant as a function of the kind of milk. Reproduction, Nutrition, Development 1986, 26:745-753.
103. Morrow A.L., Ruiz-Palacios G.M., Altaye M., Jiang X., Guerrero M.L., Meinzen-Derr J.K., Farkas T., Chaturvedi P., Pickering L.K., Newburg D.S. Human milk oligosaccharide blood group epitopes and innate immune protection against campylobacter and calicivirus diarrhea in breastfed infants. Advances in Experimental Medicine and Biology 2004, 554:443-446.
104. Mowat A.M. Anatomical basis of tolerance and immunity to intestinal antigens. Nature reviews. Immunology 2003, 3:331-341.
105. Mukai T., Asasaka T., Sato E., Mori K., Matsumoto M., Ohori H. Inhibition of binding of Helicobacter pylori to the glycolipid receptors by probiotic Lactobacillus reuteri. FEMS Immunology and Medical Microbiology 2002, 32:105-110.
106. Muller C.A., Autenrieth I.B., Peschel A. Innate defenses of the intestinal epithelial barrier. Cellular and Molecular Life Sciences 2005, 62:1297-1307.
107. Mylonakis E., Ryan E.T., Calderwood S.B. Clostridium difficile-associated diarrhea - a review. Archives of Internal Medicine 2001, 161:525-533.
108. Mysore J.V., Wigginton T., Simon P.M., Zopf D., Heman-Ackah L.M., Dubois A. Treatment of Helicobacter pylori infection in rhesus monkeys using a novel antiadhesion compound. Gastroenterology 1999, 117:1316-1325.
109. Nakajima K., Tamura N., Kobayashi-Hattori K., Yoshida T., Hara-Kudo Y., Ikedo M., Sugita-Konishi Y., Hattori M. Prevention of intestinal infection by glycomacropeptide. Bioscience, Biotechnology, and Biochemistry 2005, 69:2294-2301.
110. Newburg D.S., Ashkenazi S., Cleary T.G. Human Milk Contains the Shiga Toxin and Shiga-like Toxin Receptor Glycolipid Gb3. The Journal of Infectious Diseases 1992, 166(4):832-836.
111. Newburg D.S., Pickering L.K., McCluer R.H., Cleary T.G. Fucosylated oligosaccharides of human milk protect suckling mice from heat-stabile enterotoxin of Escherichia coli. Journal of Infectious Diseases 1990, 162:1075-1080.
112. Newburg D.S., Chaturvedi P., Lopez E.L., Devoto S., Fayad A., Cleary T.G. Susceptibility to hemolytic-uremic syndrome relates to erythrocyte glycosphingolipid patterns. Journal of Infectious Diseases 1993, 168:476-479.
113. Newburg D.S., Ruiz-Palacios G.M., Altaye M., Chaturvedi P., Guerrero M.L., Meinzen-Derr J.K., Morrow A.L. Human milk alphal, 2-linked fucosylated oligosaccharides decrease risk of diarrhea due to stable toxin of E. coli in breastfed infants. Advances in Experimental Medicine and Biology 2004, 554:457-461.
114. Newburg D.S., Ruiz-Palacios G.M., Morrow A.L. Human milk glycans protect infants against enteric pathogens. Annual Review of Nutrition 2005, 25:37-58.
115. Newell D.G. Animal models of Campylobacter jejuni colonization and disease and the lessons to be learned from similar Helicobacter pylori models. Society For Applied Microbiology Symposium Series 2001, 57S-67S.
116. Ninonuevo M.R., Ward R.E., LoCascio R.G., German J.B., Freeman S.L., Barboza M., Mills D.A., Lebrilla C.B. Methods for the quantitation of human milk oligosaccharides in bacterial fermentation by mass spectrometry. Analytical Biochemistry 2007, 361:15-23.
117. Odenbreit S., Faller G., Haas R. Role of the alpAB proteins and lipopolysaccharide in adhesion of Helicobacter pylori to human gastric tissue. International Journal of Medical Microbiology 2002, 292:247-256.
118. Ofek I., Hasty D.L., Sharon N. Anti-adhesion therapy of bacterial diseases: prospects and problems. FEMS Immunology and Medical Microbiology 2003, 38:181-191.
119. Ogra P.L. Developmental aspects of the mucosal immune system: role of external environment, mucosal microflora and milk. Breast-Feeding: Early Influences on Later Health 2009, 639:41-56.
120. O'Mahony R., Al-Khtheeri H., Weerasekera D., Fernando N., Vaira D., Holton J., Basset C. Bactericidal and anti-adhesive properties of culinary and medicinal plants against Helicobacter pylori. World Journal of Gastroenterology 2005, 11:7499-7507.
121. Patsos G., Corfield A. Management of the human mucosal defensive barrier: evidence for glycan legislation. Biological Chemistry 2009, 390:581-590.
122. Peek R.M. Pathogenesis of Helicobacter pylori infection. Springer Seminars in Immunopathology 2005, 27:197-215.
123. Pieters R.J. Intervention with bacterial adhesion by multivalent carbohydrates. Medicinal Research Reviews 2007, 27:796-816.
124. Poutanen S.M., Simor A.E. Clostridium difficile-associated diarrhea in adults. Canadian Medical Association Journal 2004, 171:51-58.
125. Reguigne-Arnould I., Couillin P., Mollicone R., Faure S., Fletcher A., Kelly R.J., Lowe J.B., Oriol R. Relative positions of two clusters of human alpha-l-fucosyltransferases in 19q (FUT1-FUT2) and 19p (FUT6-FUT3-FUT5) within the microsatellite genetic map of chromosome 19. Cytogenetics and Cell Genetics 1995, 71:158-162.
126. Roberton A.M., Wiggins R., Horner P.J., Greenwood R., Crowley T., Fernandes A., Berry M., Corfield A.P. A novel bacterial mucinase, glycosulfatase, is associated with bacterial vaginosis. Journal of Clinical Microbiology 2005, 43:5504-5508.
127. Roche N., Ilver D., Angstrom J., Barone S., Telford J.L., Teneberg S. Human gastric glycosphingolipids recognized by Helicobacter pylori vacuolating cytotoxin VacA. Microbes and Infection 2007, 9:605-614.
128. Ruas-Madiedo P., Gueimonde M., Margolles A., de los Reyes-Gavilán C.G., Salminen S. Exopolysaccharides produced by probiotic strains modify the adhesion of probiotics and enteropathogens to human intestinal mucus. Journal of Food Protection 2006, 69:2011-2015.
129. Ruiz-Palacios G.M., Cervantes L.E., Ramos P., Chavez-Munguia B., Newburg D.S. Campylobacter jejuni binds intestinal H(O) antigen (Fuc α 1, 2Gal β 1, 4GlcNAc), and fucosyloligosaccharides of human milk inhibit its binding and infection. Journal of Biological Chemistry 2003, 278:14,112-14,120.
130. Russell R.G., Blake D.C. Cell association and invasion of Caco-2 cells by Campylobacter jejuni. Infection and Immunity 1994, 62:3773-3779.
131. Sansonetti P.J. War and peace at mucosal surfaces. Nature Reviews Immunology 2004, 4:953-964.
132. Schengrund C.L. "Multivalent" saccharides: development of new approaches for inhibiting the effects of glycosphingolipid-binding pathogens. Biochemical Pharmacology 2003, 65:699-707.
133. Sela D.A., Chapman J., Adeuya A., Kim J.H., Chen F., Whitehead T.R., Lapidus A., Rokhsar D.S., Lebrilla C.B., German J.B., et al. The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome. Proceedings of the National Academy of Science of the United States of America 2008, 105:18,964-18,969.
134. Servin A.L., Coconnier M.H. Adhesion of probiotic strains to the intestinal mucosa and interaction with pathogens. Best Practice & Research. Clinical Gastroenterology 2003, 17:741-754.
135. Sharon N. Bacterial lectins, cell-cell recognition and infectious disease. FEBS Letters 1987, 217:145-157.
136. Sharon N. Carbohydrates as future anti-adhesion drugs for infectious diseases. Biochimica et Biophysica Acta 2006, 1760:527-537.
137. Sherman P.M., Johnson-Henry K.C., Yeung H.P., Ngo P.S.C., Goulet J., Tompkins T.A. Probiotics reduce enterohemorrhagic Escherichia coli O157: H7- and enteropathogenic E. coli O127: H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements. Infection and Immunity 2005, 73:5183-5188.
138. Sherman P.M., Ossa J.C., Wine E. Bacterial infections: new and emerging enteric pathogens. Current Opinion in Gastroenterology 2010, 26:1-4.
139. Sheu S.M., Sheu B.S., Yang H.B., Lei H.Y., Wu J.J. Anti-Lewis X antibody promotes Helicobacter pylori adhesion to gastric epithelial cells. Infection and Immunity 2007, 75:2661-2667.
140. Shmuely H., Burger O., Neeman I., Yahav J., Samra Z., Niv Y., Sharon N., Weiss E., Athamna A., Tabak M., Ofek I. Susceptibility of Helicobacter pylori isolates to the antiadhesion activity of a high-molecular-weight constituent of cranberry. Diagnostic Microbiology and Infectious Disease 2004, 50:231-235.
141. Shoaf-Sweeney K.D., Hutkins R.W. Adherence, anti-adherence, and oligosaccharides preventing pathogens from sticking to the host. Advances in Food Nutrition and Research 2009, 55:101-161.
142. Simon P.M., Goode P.L., Mobasseri A., Zopf D. Inhibition of Helicobacter pylori binding to gastrointestinal epithelial cells by sialic acid-containing oligosaccharides. Infection and Immunity 1997, 65:750-757.
143. Sinclair H.R., Smejkal C.W., Glister C., Kemp F., van den Heuvel E., de Slegte J., Gibson G.R., Rastall R.A. Sialyloligosaccharides inhibit cholera toxin binding to the GM1 receptor. Carbohydrate Research 2008, 343:2589-2594.
144. Stahl B., Thurl S., Zeng J.R., Karas M., Hillenkamp F., Steup M., Sawatzki G. Oligosaccharides from human-milk as revealed by matrix-assisted laser-desorption ionization mass-spectrometry. Analytical Biochemistry 1994, 223:218-226.
145. Sudha P.S., Devaraj H., Devaraj N. Adherence of Shigella dysenteriae 1 to human colonic mucin. Current Microbiology 2001, 42:381-387.
146. Suerbaum S., Josenhans C. Helicobacter pylori evolution and phenotypic diversification in a changing host. Nature Reviews Microbiology 2007, 5:441-452.
147. Sugita-Konishi Y., Sakanaka S., Sasaki K., Juneja L.R., Noda T., Amano F. Inhibition of bacterial adhesion and Salmonella infection in BALB/c mice by sialyloligosaccharides and their derivatives from chicken egg yolk. Journal of Agricultural Food Chemistry 2002, 50:3607-3613.
148. Suzuki K., Meek B., Doi Y., Muramatsu M., Chiba T., Honjo T., Fagarasan S. Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut. Proceedings of the National Academy of Science of the United States of America 2004, 101:1981-1986.
149. Tonna I., Welsby P.D. Pathogenesis and treatment of Clostridium difficile infection. Post Graduate Medical Journal 2005, 81:367-369.
150. Torres J., Backert S. Pathogenesis of Helicobacter pylori infection. Helicobacter 2008, 13(Suppl 1):13-17.
151. Tucker K.D., Wilkins T.D. Toxin A of Clostridium difficile binds to the human carbohydrate antigens I, X, and Y. Infection and Immunity 1991, 59:73-78.
152. Urashima T., Saito T., Nakamura T., Messer M. Oligosaccharides of milk and colostrum in non-human mammals. Glycoconjugate Journal 2001, 18:357-371.
153. Utt M., Wadstrom T. Identification of heparan sulphate binding surface proteins of Helicobacter pylori: inhibition of heparan sulphate binding with sulphated carbohydrate polymers. Journal of Medical Microbiology 1997, 46:541-546.
154. van der Woude M.W., Baumler A.J. Phase and antigenic variation in bacteria. Clinical Microbiology Reviews 2004, 17:581-611.
155. Voth D.E., Ballard J.D. Clostridium difficile toxins: mechanism of action and role in disease. Clinical Microbiology Reviews 2005, 18:247-263.
156. Waligora A.J., Hennequin C., Mullany P., Bourlioux P., Collignon A., Karjalainen T. Characterization of a cell surface protein of Clostridium difficile with adhesive properties. Infection and Immunity 2001, 69:2144-2153.
157. Wang X., Hirmo S., Willen R., Wadstrom T. Inhibition of Helicobacter pylori infection by bovine milk glycoconjugates in a BAlb/cA mouse model. Journal of Medical Microbiology 2001, 50:430-435.
158. Weir E., Flegel K. Protecting against Clostridium difficile illness. Canadian Medical Association Journal 2005, 172:1178.
159. Wen S., Moss S.F. Helicobacter pylori virulence factors in gastric carcinogenesis. Cancer Letters 2009, 282:1-8.
160. Xu H.T., Zhao Y.F., Lian Z.X., Fan B.L., Zhao Z.H., Yu S.Y., Dai Y.P., Wang L.L., Niu H.L., Li N., Hammarstrom L., Boren T., Sjostrom R. Effects of fucosylated milk of goat and mouse on Helicobacter pylori binding to Lewis b antigen. World Journal of Gastroenterology 2004, 10:2063-2066.
161. Yarema K.J. Handbook of Carbohydrate Engineering 2005, Taylor & Francis, New York.
162. Young K.T., Davis L.M., Dirita V.J. Campylobacter jejuni: molecular biology and pathogenesis. Nature Reviews Microbiology 2007, 5:665-679.